Скачать или смотреть Cardinal Health Center for Theranostics Advancement: Supporting the Growth of Theranostics Globally

Cardinal Health’s Center for Theranostics Advancement in Indianapolis, Indiana, is helping to shape the future of precision medicine by providing pharmaceutical innovators the solutions they need at every stage of the product lifecycle. From assisting with early feasibility studies and clinical manufacturing operations, to large-scale production and distribution, the Center helps accelerate the development of a wide range of diagnostic drugs and novel therapies.

The Center for Theranostics Advancement also offers cGMP-compliant Actinium-225 at commercial scale in collaboration with TerraPower. New drugs containing the isotope Actinium-225 have the potential to become the next generation of cancer treatment, offering a significant milestone in increasing access to potential new cancer therapies for patients.